GGrantIndex
← Search

ACTG 379 DISCONTINUING MAINTENANCE THERAPY FOR CMV RETINITIS

$0M01FY2000RRNIH

University Of North Carolina Chapel Hill, Chapel Hill NC

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →
ACTG 379 DISCONTINUING MAINTENANCE THERAPY FOR CMV RETINITIS · GrantIndex